Bellicum Pharmaceuticals

Audentes Therapeutics

Audentes is a biotechnology company committed to the development and commercialization of innovative new treatments for people with serious, rare muscle diseases through the application of adeno-associated virus gene therapy technology.

Select Venture Capital & Financial Partners

5AM Ventures Cowen & Co Deerfield Management Company Foresite Capital OrbiMed Advisors RA Capital Management Redmile Group Rock Springs Capital Sofinnova Ventures T. Rowe Price Associates Venrock Versant Ventures